Carl June wins Breakthrough Prize in Life Sciences for development of CAR-T cell immunotherapy thedp.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedp.com Daily Mail and Mail on Sunday newspapers.
Penn Medicine s Carl June to receive 2024 Breakthrough Prize in Life Sciences upenn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from upenn.edu Daily Mail and Mail on Sunday newspapers.
Faculty from the School of Veterinary Medicine and Perelman School of Medicine were honored at the Association for Research in Vision and Ophthalmology meeting in New Orleans.
Lifelong Roger Maris Fan Shares Stories Of The Two During Inaugural Roger Maris All Star Week kvrr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kvrr.com Daily Mail and Mail on Sunday newspapers.
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing
News provided by
Share this article
Share this article
SOUTH SAN FRANCISCO, Calif., May 5, 2021 /PRNewswire/
Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, today announced it has secured $82 million in a Series B round, bringing total funding to date to $100 million. The round was led by new investor Decheng Capital and co-led by existing investor Eclipse Ventures. Skyviews Life Science joined as a new investor, with previous investor 8VC also participating.
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing